Assessing and Treating Pediatric Clients With Mood Disorders NURS 6630N

Assignment: Assessing and Treating Pediatric Clients With Mood Disorders NURS 6630N

The Assignment
Examine Case Study: An African American Child Suffering From Depression. You will
be asked to make three decisions concerning the medication to prescribe to this client.
Be sure to consider factors that might impact the client’s pharmacokinetic and
pharmacodynamic processes. Assessing and Treating Pediatric Clients With Mood Disorders NURS 6630N
 At each decision point stop to complete the following:
o Decision #1
 Which decision did you select?
 Why did you select this decision? Support your response with evidence and references to the
Learning Resources.
 What were you hoping to achieve by making this decision? Support your response with
evidence and references to the Learning Resources.
 Explain any difference between what you expected to achieve with Decision #1 and the results
of the decision. Why were they different?
o Decision #2
 Why did you select this decision? Support your response with evidence and references to the
Learning Resources.
 What were you hoping to achieve by making this decision? Support your response with
evidence and references to the Learning Resources.
 Explain any difference between what you expected to achieve with Decision #2 and the results
of the decision. Why were they different?
o Decision #3
 Why did you select this decision? Support your response with evidence and references to the
Learning Resources.
 What were you hoping to achieve by making this decision? Support your response with
evidence and references to the Learning Resources. Assessing and Treating Pediatric Clients With Mood Disorders NURS 6630N
 Explain any difference between what you expected to achieve with Decision #3 and the results
of the decision. Why were they different?
 Also include how ethical considerations might impact your treatment plan and communication
with clients.
Note: Support your rationale with a minimum of three academic resources. While you
may use the course text to support your rationale, it will not count toward the resource
requirement.
By Day 7
Submit your Assignment.
Submission and Grading Information
To submit your completed Assignment for review and grading, do the following:
 Please save your Assignment using the naming convention “WK2Assgn+last name+first
initial.(extension)” as the name.
 Click the Week 2 Assignment Rubric to review the Grading Criteria for the Assignment.
 Click the Week 2 Assignment link. You will also be able to “View Rubric” for grading criteria
from this area.
 Next, from the Attach File area, click on the Browse My Computer button. Find the document
you saved as “WK2Assgn+last name+first initial.(extension)” and click Open.
 If applicable: From the Plagiarism Tools area, click the checkbox for I agree to submit my
paper(s) to the Global Reference Database.
 Click on the Submit button to complete your submission.
Grading Criteria

To access your rubric:
Week 2 Assignment Rubric
Check Your Assignment Draft for Authenticity
To check your Assignment draft for authenticity:
Submit your Week 2 Assignment draft and review the originality report. Assessing and Treating Pediatric Clients With Mood Disorders NURS 6630N
Submit Your Assignment by Day 7
To submit your Assignment:
Week 2 Assignment

Making Connections

Now that you have:
 Assessed pediatric clients presenting with mood disorders
 Developed personalized plans of antidepressant therapy for pediatric clients
 Examined factors that influence pharmacokinetic and pharmacodynamic processes in pediatric
clients requiring antidepressant therapy
 Explored ethical and legal implications of prescribing antidepressant therapy to pediatric clients
Next week, you will build on your assessment and treatment skills as you examine adult
and geriatric clients presenting for antidepressant therapy.

ORDER NOW FOR AN ORIGINAL PAPER ASSIGNMENT: Assignment: Assessing and Treating Pediatric Clients With Mood Disorders NURS 6630N
Learning Resources
Note: To access this week’s required library resources, please click on the link to the
Course Readings List, found in the Course Materials section of your Syllabus.
Required Readings
Note: All Stahl resources can be accessed through this link provided.
Stahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and
practical applications (4th ed.). New York, NY: Cambridge University Press.

Note: To access the following chapters, click on the Essential Psychopharmacology,
4th ed tab on the Stahl Online website and select the appropriate chapter. Be sure to
read all sections on the left navigation bar for each chapter.
 Chapter 6, “Mood Disorders”
 Chapter 7, “Antidepressants”
Stahl, S. M. (2014b). The prescriber’s guide (5th ed.). New York, NY: Cambridge
University Press.

Note: To access the following medications, click on the The Prescriber's Guide, 5th
ed tab on the Stahl Online website and select the appropriate chapter. Be sure to read
all sections on the left navigation bar for each chapter.

Review the following medications:
 amitriptyline
 bupropion
 citalopram
 clomipramine
 desipramine
 desvenlafaxine
 doxepin
 duloxetine
 escitalopram
 fluoxetine
 fluvoxamine
 imipramine
 ketamine
 mirtazapine
 nortriptyline
 paroxetine
 selegiline
 sertraline
 trazodone
 venlafaxine
 vilazodone
 vortioxetine

Lorberg, B., Davico, C., Martsenkovskyi, D., & Vitiello, B. (2019). Principles in using
psychotropic medication in children and adolescents. In J. M. Rey & A. Martin (Eds.),
IACAPAP e-Textbook of Child and Adolescent Mental Health. Geneva: International
Association for Child and Adolescent Psychiatry and Allied Professions. Retrieved from
https://iacapap.org/content/uploads/A.7-Psychopharmacology-2019.1.pdf
Magellan Health, Inc. (2013). Appropriate use of psychotropic drugs in children and
adolescents: A clinical monograph. Retrieved from
http://www.magellanhealth.com/media/445492/magellan-psychotropicdrugs-
0203141.pdf
Poznanski, E., & Mokros, H. (1996). Child Depression Rating Scale–Revised. Los
Angeles, CA: Western Psychological Services.
Note: Retrieved from Walden Library databases.
Rao, U. (2013). Biomarkers in pediatric depression. Depression & Anxiety, 30(9), 787-
791. doi:10.1002/da.22171
Required Media
Laureate Education (2016e). Case study: An African American child suffering from
depression [Interactive media file]. Baltimore, MD: Author. Assessing and Treating Pediatric Clients With Mood Disorders NURS 6630N

Note: This case study will serve as the foundation for this week’s Assignment.
Optional Resources
El Marroun, H., White, T., Verhulst, F., & Tiemeier, H. (2014). Maternal use of
antidepressant or anxiolytic medication during pregnancy and childhood
neurodevelopmental outcomes: A systematic review. European Child & Adolescent
Psychiatry, 23(10), 973–992. doi:10.1007/s00787-014-0558-3
Gordon, M. S., & Melvin, G. A. (2014). Do antidepressants make children and
adolescents suicidal? Journal of Pediatrics and Child Health, 50(11), 847–854.
doi:10.1111/jpc.12655
Seedat, S. (2014). Controversies in the use of antidepressants in children and
adolescents: A decade since the storm and where do we stand now? Journal of Child &
Adolescent Mental Health, 26(2), iii–v. doi:10.2989/17280583.2014.938497
To prepare for this Assignment:
 Review this week’s Learning Resources. Consider how to assess and treat pediatric clients
requiring antidepressant therapy.